Investment Partners Asset Management »

Vaneck Vectors Pharmaceutical etf shares owned by Investment Partners Asset Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Investment Partners Asset Management from 13F filings

Historical chart of Investment Partners Asset Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Investment Partners Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Investment Partners Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $395k 4.4k 90.70
2023-12-31 $354k 4.4k 81.37

More positions owned by Investment Partners Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Global X Fds Rate Preferred (PFFV)
Global X Fds S&p 500 Covered (XYLD)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Nasdaq 100 Cover (QYLD)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Betabuilders Usd (BBHY)
Meta Platforms Cl A (META)
Vaneck Etf Trust Bdc Income Etf (BIZD)
Amazon (AMZN)
International Business Machines (IBM)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Ishares Tr 0-5 Yr Tips Etf (STIP)

View all positions for Investment Partners Asset Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf